SLC1A5 and neoplasm: As shown in Figure 5, SLC1A5 was tightly associated with apoptosis, cellular response to hypoxia, degradation of ECM, EMT, G2M checkpoint, IL-10 anti-inflammatory signaling pathway, inflammatory response, P53 pathway, PI3K-AKT-mTOR pathway and tumor proliferation signature.